We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

182 hedge funds and large institutions have $1.04B invested in Ariad Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 45 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more funds holding in top 10

Funds holding in top 10: 2 → 7 (+5)

105% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 20

44% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 45

20% more capital invested

Capital invested by funds: $867M → $1.04B (+$169M)

13% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $12.2M

12% more funds holding

Funds holding: 162 → 182 (+20)

Holders
182
Holders Change
+20
Holders Change %
+12.35%
% of All Funds
4.86%
Holding in Top 10
7
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+250%
% of All Funds
0.19%
New
41
Increased
65
Reduced
45
Closed
20
Calls
$13.8M
Puts
$12.2M
Net Calls
+$1.64M
Net Calls Change
-$1.88M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$24.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.4M
3
Goldman Sachs
Goldman Sachs
New York
+$8.84M
4
CC
CQS Cayman
Cayman Islands
+$8.49M
5
Invesco
Invesco
Georgia
+$6.32M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$35.6M
2
PI
Putnam Investments
Massachusetts
-$23.9M
3
CCM
Camber Capital Management
Massachusetts
-$10.5M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$8.2M
5
PC
PointState Capital
New York
-$6.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
Parallax Volatility Advisers
51
Parallax Volatility Advisers
California
$2.5M +$2.53M +337,689 New
Point72 Asset Management
52
Point72 Asset Management
Connecticut
$2.22M +$2.25M +300,000 New
IIM
53
Ironwood Investment Management
Massachusetts
$2.17M -$235K -31,284 -10%
AIMCA
54
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.17M -$265K -35,340 -11%
CS
55
Credit Suisse
Switzerland
$2.14M +$140K +18,624 +7%
Swiss National Bank
56
Swiss National Bank
Switzerland
$2.09M -$85.5K -11,400 -4%
CS
57
Candriam SCA
Luxembourg
$1.92M +$675K +90,000 +53%
Millennium Management
58
Millennium Management
New York
$1.89M -$278K -37,115 -13%
PIM
59
Platinum Investment Management
Australia
$1.85M – – –
Ameriprise
60
Ameriprise
Minnesota
$1.65M -$627K -83,545 -27%
UBS Group
61
UBS Group
Switzerland
$1.54M +$619K +82,531 +66%
1CM
62
1492 Capital Management
Wisconsin
$1.5M – – –
DCM
63
Dynamic Capital Management
Jersey
$1.4M +$1.42M +188,768 New
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$1.39M +$110K +14,675 +8%
New York State Common Retirement Fund
65
New York State Common Retirement Fund
New York
$1.34M +$131K +17,500 +11%
BA
66
BlackRock Advisors
Delaware
$1.33M +$234K +31,123 +21%
FM
67
Family Management
New York
$1.33M +$9.38K +1,250 +0.7%
Simplex Trading
68
Simplex Trading
Illinois
$1.31M +$1,000K +133,255 +298%
Squarepoint
69
Squarepoint
New York
$1.26M +$705K +93,903 +122%
MIG
70
Mariner Investment Group
New York
$1.25M +$197K +26,200 +18%
ProShare Advisors
71
ProShare Advisors
Maryland
$1.21M +$21.9K +2,914 +2%
BG
72
BlackRock Group
United Kingdom
$1.21M -$60.6K -8,075 -5%
NFA
73
Nationwide Fund Advisors
Ohio
$1.16M +$369K +49,171 +46%
FAM
74
Fred Alger Management
New York
$1.12M +$670K +89,300 +144%
VKH
75
Virtu KCG Holdings
New York
$1.11M +$882K +117,565 +362%
1 2
3
4 5

ARIA Hedge Fund Activity: Q2 2016 in Review

182 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2016, worth a combined $1.04B — up 20% from $867M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ARIA positions and 20 closed out — a net gain of 21 holders — while 65 added to existing stakes and 45 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $24.5M. The largest seller was Adage Capital Partners, cutting an estimated $35.6M.

  • 182 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2016, up from 162 in Q1 2016.
  • Funds reported $1.04B of Ariad Pharmaceuticals Inc stock for Q2 2016, up 20% quarter-over-quarter.
  • 41 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2016 and 20 closed out, a net change of +21 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q2 2016 was Consonance Capital Management, an estimated $24.5M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q2 2016 was Adage Capital Partners, an estimated $35.6M sold.

Based on aggregated 13F filings for Q2 2016.